Journey Medical Corporation to Participate in October 2025 Investor Conferences
Journey Medical (Nasdaq: DERM) said its management team will participate in two investor conferences in October 2025 in New York City.
Events and formats:
- ROTH Healthcare Opportunities Conference — Thursday, October 9, 2025 — 1x1 meetings.
- The ThinkEquity Conference — Thursday, October 30, 2025 — presentation and 1x1 meetings.
The company will engage investors through one-on-one meetings and a public presentation on the listed dates.
Journey Medical (Nasdaq: DERM) ha detto che il suo team di gestione parteciperà a due conferenze degli investitori nell'ottobre 2025 a New York City.
Eventi e formati:
- ROTH Healthcare Opportunities Conference — giovedì, 9 ottobre 2025 — incontri 1x1.
- The ThinkEquity Conference — giovedì, 30 ottobre 2025 — presentazione e incontri 1x1.
L'azienda interagirà con gli investitori tramite incontri one-to-one e una presentazione pubblica nelle date elencate.
Journey Medical (Nasdaq: DERM) dijo que su equipo de gestión participará en dos conferencias de inversionistas en octubre de 2025 en la ciudad de Nueva York.
Eventos y formatos:
- ROTH Healthcare Opportunities Conference — jueves, 9 de octubre de 2025 — reuniones 1x1.
- The ThinkEquity Conference — jueves, 30 de octubre de 2025 — presentación y reuniones 1x1.
La empresa se comunicará con los inversionistas a través de reuniones uno a uno y una presentación pública en las fechas indicadas.
Journey Medical (나스닥: DERM)의 경영진은 2025년 10월 뉴욕시에서 두 차례의 투자자 컨퍼런스에 참여할 것이라고 밝혔습니다.
이벤트와 형식:
- ROTH Healthcare Opportunities Conference — 2025년 10월 9일목요일 — 1:1 미팅.
- The ThinkEquity Conference — 2025년 10월 30일목요일 — 발표 및 1:1 미팅.
회사는 명시된 날짜에 일대일 미팅과 공개 발표를 통해 투자자들과 소통할 예정입니다.
Journey Medical (Nasdaq: DERM) a déclaré que son équipe de direction participera à deux conférences d'investisseurs en octobre 2025 à New York.
Événements et formats :
- ROTH Healthcare Opportunities Conference — jeudi 9 octobre 2025 — réunions en tête-à-tête.
- The ThinkEquity Conference — jeudi 30 octobre 2025 — présentation et réunions en tête-à-tête.
L'entreprise dialoguera avec les investisseurs lors de réunions en tête-à-tête et d'une présentation publique aux dates indiquées.
Journey Medical (Nasdaq: DERM) gab bekannt, dass das Management-Team an zwei Investorenkonferenzen im Oktober 2025 in New York City teilnehmen wird.
Ereignisse und Formate:
- ROTH Healthcare Opportunities Conference — Donnerstag, 9. Oktober 2025 — 1-zu-1-Meetings.
- The ThinkEquity Conference — Donnerstag, 30. Oktober 2025 — Präsentation und 1-zu-1-Meetings.
Das Unternehmen wird über One-on-One-Meetings und eine öffentliche Präsentation an den aufgeführten Terminen Kontakt zu Investoren aufnehmen.
قالت Journey Medical (ناسداك: DERM) إن فريق إدارتها سيشارك في مؤتمرين للمستثمرين في أكتوبر 2025 في مدينة نيويورك.
الفعاليات والصيغ:
- ROTH Healthcare Opportunities Conference — الخميس، 9 أكتوبر 2025 — اجتماعات وجهاً لوجه 1×1.
- The ThinkEquity Conference — الخميس، 30 أكتوبر 2025 — عرض وت ملاقات وجهاً لوجه 1×1.
ستتواصل الشركة مع المستثمرين من خلال الاجتماعات الفردية وعرض عام في التواريخ المذكورة.
Journey Medical (纳斯达克: DERM) 表示其管理团队将于 2025 年 10 月在纽约市参加两场投资者会议。
活动与形式：
- ROTH Healthcare Opportunities Conference — 2025 年 10 月 9 日，星期四 — 一对一会谈。
- The ThinkEquity Conference — 2025 年 10 月 30 日，星期四 — 演讲与一对一会谈。
公司将通过一对一会谈和在上述日期的公开演讲与投资者进行沟通。
- None.
- None.
SCOTTSDALE, Ariz., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that members of Journey Medical’s management team will participate in two October 2025 investor conferences.
Details of the events are as follows:
4th Annual ROTH Healthcare Opportunities Conference
Date: Thursday, October 9, 2025
Location: New York City
Format: 1x1 Meetings
The ThinkEquity Conference
Date: Thursday, October 30, 2025
Location: New York City
Format: Presentation and 1x1 Meetings
About Journey Medical Corporation
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”) is a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions through its efficient sales and marketing model. The Company currently markets eight branded FDA-approved prescription drugs that help treat and heal common skin conditions. The Journey Medical team comprises industry experts with extensive experience in developing and commercializing some of dermatology’s most successful prescription brands. Journey Medical is located in Scottsdale, Arizona and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical’s common stock is registered under the Securities Exchange Act of 1934, as amended, and it files periodic reports with the U.S. Securities and Exchange Commission (“SEC”). For additional information about Journey Medical, visit www.journeymedicalcorp.com.
Company Contact:
Jaclyn Jaffe
(781) 652-4500
ir@jmcderm.com
Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 591-2839
tplohoros@6degreespr.com
FAQ
When will Journey Medical (DERM) attend the ROTH Healthcare Opportunities Conference in 2025?
What is Journey Medical's schedule at The ThinkEquity Conference for October 2025?
How can investors access Journey Medical's ThinkEquity presentation on October 30, 2025?
Which Journey Medical executives will attend the October 2025 investor conferences?
Will Journey Medical (DERM) hold one-on-one meetings at the October 2025 conferences?
